Eintrag weiter verarbeiten
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis
Gespeichert in:
| Zeitschriftentitel: | Allergy |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | Allergy, 44, 1989, 6, S. 437-441 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. |
|---|---|
| author |
BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. |
| spellingShingle |
BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. Allergy Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis Immunology Immunology and Allergy |
| author_sort |
boner, a. l. |
| spelling |
BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. 0105-4538 1398-9995 Wiley Immunology Immunology and Allergy http://dx.doi.org/10.1111/j.1398-9995.1989.tb04176.x <jats:p>The safety and efficacy of loratadine was compared with that of dexchlorpheniramine in children with allergic rhinitis. Twenty‐one children received loratadine 0.11–0.24 mg/kg ideal body weight once daily and 19 dexchlorpheniramine 0.10–0.23 mg/kg every 8 h (0.30–0.69 mg/24 h) for 14 consecutive days. Both loratadine and dexchlorpheniramine were effective in reducing nasal and ocular symptoms in allergic children. Substantial improvement in allergy symptoms was observed at the first evaluation (day 3 of treatment) and was maintained for the study duration. No significant trend of abnormality in laboratory parameters was observed. Drowsiness was present only in the dexchlorpheniramine‐treated group. Loratadine appears to be a simple, effective and safe therapy for seasonal allergic rhinitis.</jats:p> Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis Allergy |
| doi_str_mv |
10.1111/j.1398-9995.1989.tb04176.x |
| facet_avail |
Online |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4xOTg5LnRiMDQxNzYueA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4xOTg5LnRiMDQxNzYueA |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
| imprint |
Wiley, 1989 |
| imprint_str_mv |
Wiley, 1989 |
| issn |
0105-4538 1398-9995 |
| issn_str_mv |
0105-4538 1398-9995 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
boner1989efficacyandsafetyofloratadinesuspensioninthetreatmentofchildrenwithallergicrhinitis |
| publishDateSort |
1989 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Allergy |
| source_id |
49 |
| title |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_unstemmed |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_full |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_fullStr |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_full_unstemmed |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_short |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_sort |
efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| topic |
Immunology Immunology and Allergy |
| url |
http://dx.doi.org/10.1111/j.1398-9995.1989.tb04176.x |
| publishDate |
1989 |
| physical |
437-441 |
| description |
<jats:p>The safety and efficacy of loratadine was compared with that of dexchlorpheniramine in children with allergic rhinitis. Twenty‐one children received loratadine 0.11–0.24 mg/kg ideal body weight once daily and 19 dexchlorpheniramine 0.10–0.23 mg/kg every 8 h (0.30–0.69 mg/24 h) for 14 consecutive days. Both loratadine and dexchlorpheniramine were effective in reducing nasal and ocular symptoms in allergic children. Substantial improvement in allergy symptoms was observed at the first evaluation (day 3 of treatment) and was maintained for the study duration. No significant trend of abnormality in laboratory parameters was observed. Drowsiness was present only in the dexchlorpheniramine‐treated group. Loratadine appears to be a simple, effective and safe therapy for seasonal allergic rhinitis.</jats:p> |
| container_issue |
6 |
| container_start_page |
437 |
| container_title |
Allergy |
| container_volume |
44 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792337053005905932 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:10:13.035Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Efficacy+and+safety+of+loratadine+suspension+in+the+treatment+of+children+with+allergic+rhinitis&rft.date=1989-08-01&genre=article&issn=1398-9995&volume=44&issue=6&spage=437&epage=441&pages=437-441&jtitle=Allergy&atitle=Efficacy+and+safety+of+loratadine+suspension+in+the+treatment+of+children+with+allergic+rhinitis&aulast=ANDREOLI&aufirst=A.&rft_id=info%3Adoi%2F10.1111%2Fj.1398-9995.1989.tb04176.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792337053005905932 |
| author | BONER, A. L., MIGLIORANZI, P., RICHELLI, C., MARCHESI, E., ANDREOLI, A. |
| author_facet | BONER, A. L., MIGLIORANZI, P., RICHELLI, C., MARCHESI, E., ANDREOLI, A., BONER, A. L., MIGLIORANZI, P., RICHELLI, C., MARCHESI, E., ANDREOLI, A. |
| author_sort | boner, a. l. |
| container_issue | 6 |
| container_start_page | 437 |
| container_title | Allergy |
| container_volume | 44 |
| description | <jats:p>The safety and efficacy of loratadine was compared with that of dexchlorpheniramine in children with allergic rhinitis. Twenty‐one children received loratadine 0.11–0.24 mg/kg ideal body weight once daily and 19 dexchlorpheniramine 0.10–0.23 mg/kg every 8 h (0.30–0.69 mg/24 h) for 14 consecutive days. Both loratadine and dexchlorpheniramine were effective in reducing nasal and ocular symptoms in allergic children. Substantial improvement in allergy symptoms was observed at the first evaluation (day 3 of treatment) and was maintained for the study duration. No significant trend of abnormality in laboratory parameters was observed. Drowsiness was present only in the dexchlorpheniramine‐treated group. Loratadine appears to be a simple, effective and safe therapy for seasonal allergic rhinitis.</jats:p> |
| doi_str_mv | 10.1111/j.1398-9995.1989.tb04176.x |
| facet_avail | Online |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzOTgtOTk5NS4xOTg5LnRiMDQxNzYueA |
| imprint | Wiley, 1989 |
| imprint_str_mv | Wiley, 1989 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
| issn | 0105-4538, 1398-9995 |
| issn_str_mv | 0105-4538, 1398-9995 |
| language | English |
| last_indexed | 2024-03-01T15:10:13.035Z |
| match_str | boner1989efficacyandsafetyofloratadinesuspensioninthetreatmentofchildrenwithallergicrhinitis |
| mega_collection | Wiley (CrossRef) |
| physical | 437-441 |
| publishDate | 1989 |
| publishDateSort | 1989 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Allergy |
| source_id | 49 |
| spelling | BONER, A. L. MIGLIORANZI, P. RICHELLI, C. MARCHESI, E. ANDREOLI, A. 0105-4538 1398-9995 Wiley Immunology Immunology and Allergy http://dx.doi.org/10.1111/j.1398-9995.1989.tb04176.x <jats:p>The safety and efficacy of loratadine was compared with that of dexchlorpheniramine in children with allergic rhinitis. Twenty‐one children received loratadine 0.11–0.24 mg/kg ideal body weight once daily and 19 dexchlorpheniramine 0.10–0.23 mg/kg every 8 h (0.30–0.69 mg/24 h) for 14 consecutive days. Both loratadine and dexchlorpheniramine were effective in reducing nasal and ocular symptoms in allergic children. Substantial improvement in allergy symptoms was observed at the first evaluation (day 3 of treatment) and was maintained for the study duration. No significant trend of abnormality in laboratory parameters was observed. Drowsiness was present only in the dexchlorpheniramine‐treated group. Loratadine appears to be a simple, effective and safe therapy for seasonal allergic rhinitis.</jats:p> Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis Allergy |
| spellingShingle | BONER, A. L., MIGLIORANZI, P., RICHELLI, C., MARCHESI, E., ANDREOLI, A., Allergy, Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis, Immunology, Immunology and Allergy |
| title | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_full | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_fullStr | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_full_unstemmed | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_short | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_sort | efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| title_unstemmed | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis |
| topic | Immunology, Immunology and Allergy |
| url | http://dx.doi.org/10.1111/j.1398-9995.1989.tb04176.x |